Author: sHq_LoGiNz

NCDs are the leading cause of death globally, representing a significant burden to people and health care systems. As many as 18 million people die annually before the age of 70 from NCDs including cardiovascular disease, cancers, chronic respiratory diseases and diabetes – with a great majority of those deaths happening in low- or lower-middle income countries.¹

Viatris’ broad portfolio of both off-patent and new, innovative medicines address many NCDs such as cardiovascular disease, diabetes, respiratory diseases, dermatology and ophthalmology. Some examples of our work to expand access across geographies in 2024 include the following:

•  Viatris entered into an exclusive licensing agreement with Lexicon Pharmaceuticals for sotagliflozin in all markets outside of the United States and Europe. Sotagliflozin was approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death, hospitalization for heart failure and urgent heart failure visit in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease and other cardiovascular risk factors.
• In the U.S., Viatris launched RYZUMVITM (phentolamine ophthalmic solution) for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents. RYZUMVI is the only U.S. commercially available FDA-approved eye drop to reverse dilation.
• Dymista was successfully launched in China to further improve treatment satisfaction for patients with moderate to severe allergic rhinitis.
• In seven countries in Europe, Viatris launched Rizmoic (naldemedine tablet), an innovative therapy with a mode of action specifically targeting the underlying cause of opioid-induced constipation.
• In Canada, Viatris launched PrGlatiramer Acetate Injection 20 mg/mL for once-daily injection, the first generic bioequivalent version of Teva’s Copaxone® 20 mg/mL, indicated for the treatment of patients with relapsing-remitting multiple sclerosis (RMMS), a chronic inflammatory disease of the central nervous system.
• In Australia, Relpax Migraine, Dymista Allergy treatments and Celebrex Relief became available to patients without a prescription, offering Australians access to acute treatment options without the need to see an HCP.
• In Japan, Viatris introduced Cystadrops Ophthalmic Solution 0.38% to dissolve cystine crystal deposits in the corneas of cystinosis patients. We also launched Sugammadex intravenous 200mg/500mg to help patients recover from muscle relaxation caused by rocuronium bromide or vecuronium bromide.
• Elidel® was approved for use by infants aged three months and older across the EU, China and other Asian countries. This milestone expands access to safe and effective treatment options for patients with atopic dermatitis, contributing to improved quality of life for millions of patients and their families.
• Neurontin NT and Neurontin M launched in India to provide additional treatments for pain.
• Apixaban, a branded generic alternative for the treatment and prevention of blood clots and to prevent stroke in people with nonvalvular atrial fibrillation, launched in the Philippines.
• Launched Zeforus (Relpax), the first eletriptan hydrobromide available in Brazil, indicated for acute migraine with or without aura.

“MS Canada estimates 90,000 Canadians are living with multiple sclerosis—one of the highest rates of MS in the world. Because of this high prevalence, and because MS affects each person differently, there is a need for a range of medicines to help manage the symptoms of the disease and other medical conditions that are commonly associated with MS.”
Jeffrey L.
Canada Country Manager, Viatris

Cardiovascular Disease

Cardiovascular disease accounts for the largest number of NCD deaths globally.² To fight this global public health threat, Viatris promotes prevention, diagnosis and treatment, leveraging the breadth of our diverse portfolio and partnerships around the world.

Examples of our work in 2024 included the following:

• Supported the creation of four podcasts for HCP education in Europe on diagnosing thrombotic disorders in a variety of clinical conditions and treating them with best-in-class clinical management. The podcasts included discussions on anticoagulation monitoring, the treatment of thrombosis in cancer patients, the optimal duration of thrombosis treatment and how to minimize the risk of thrombosis in surgical patients.
• Launched ViaHeart – or La Via del Cuore – in Italy, a cardiovascular disease awareness campaign, an omnichannel effort to help HCPs and pharmacists raise awareness on the importance of a healthy lifestyle, proper nutrition and reducing other risk factors and on the importance of medicine adherence.
• Viatris in Egypt hosted the first Neuro Summit focused on stroke patient management and treatment guidelines. This summit addressed stroke as a complication of hypertension, diabetes and dyslipidemia, and its psychological impacts.
• Viatris Türkiye supported The World Heart Federation Cholesterol Roadmap project-Türkiye, which aims to increase awareness of dyslipidemia, promote treatment and identify the barriers to treatment.

The above noted exclusive licensing agreement with Lexicon Pharmaceuticals for sotagliflozin adds another asset to Viatris’ expanding innovative portfolio in cardiovascular diseases. It further supports our joint ability to provide ready access in more markets and to patients worldwide through Viatris’ unique global infrastructure and expertise.

Hypertension

Hypertension, or high blood pressure, is a significant condition within cardiovascular disease. It increases the risk of heart disease, stroke, and other complications. In 2024, Viatris worked to raise awareness and promote treatment of hypertension in many ways, including:

• Partnered with the Saudi Hypertension Management Society (SHMS), the sole society in Saudi Arabia focused on hypertension management. The collaboration involved educational programs for HCPs covering cardiometabolic disease, diabetes and major depressive disorders, with more than 10,000 HCPs taking part. Additionally, Viatris sponsored the “Everyday Count” educational series, organized by SHMS, to boost awareness and screening of hypertension among hospitalized patients.
• Collaborated with the Philippine Society of Hypertension and a local community, marking Viatris’ first local government unit partnership to educate and screen approximately 300 patients.
• Contributed to the concept of high-quality blood pressure management, which was a significant part of the Chinese Hypertension Guideline published in 2024. To benefit more patients, the China Hypertension League (CHL) and the HOPE Asia Network initiated a deeper discussion on quality blood pressure management, involving experts from neurology, nephrology and cardiology. The HOPE
  Asia Multidisciplinary Consensus on High-Quality Hypertension Management is expected to be released at the 2025 China Hypertension Annual Congress and published in a journal by year-end.
• Hosted meetings throughout Türkiye with more than 250 HCPs as part of the Global Hypercare Project, with a focus on the importance of controlling blood pressure variability, a critical factor in hypertension management.
• Cooperated with the Bulgarian Patients Forum on a series of health podcasts, including on arterial hypertension.
• Led “Project Challenge: Hypertension and Dyslipidemia – A Continuous Challenge for Young Doctors” in Naples, Italy, with HCPs. The event was a part of a global “train the trainer” project launched in Spain in 2023.
• Blood pressure variability (BPV) is associated with an increased risk of cardiovascular–renal complications and cognitive decline. To help address gaps in clinical practice and awareness, Viatris developed a holistic BPV advocacy plan in Asia, the Middle East and Europe, with more than 10,000 HCPs reached.

Mental Health

About one in eight people in the world live with a mental health condition, the most common of which are anxiety and depressive disorders.³ While global attention on mental health has grown in recent years, especially since the COVID-19 pandemic, much work remains to build understanding, knowledge and capacity. Several factors prevent people from seeking and receiving help for mental health conditions, including poor quality of services, low levels of health literacy in mental health and stigma and discrimination. Viatris has worked with partners around the world to explore ways to improve access to mental health prevention, diagnosis and treatment.

Our work in 2024 included initiatives collectively aimed at promoting awareness, educating and training healthcare providers, conducting research and developing treatments and partnering with governments and institutions.

Promoting Awareness

• Supported “Tear Away the Silence” live podcasts by ‘mentl,’ a United Arab Emirates mental health advocacy platform. The campaign reached approximately 5.5 million people, contributing to reducing stigma and empowering people’s mental health and wellbeing journeys.
• Collaborated in Türkiye with the Association of Psychiatric Sciences and Research (PiBAD) on the “Hayata Varım” Mental Health Disease Awareness Campaign to break down barriers to mental health care access.
• Continued to support the Yellow September Campaign, “Love Me, Love Myself,” in partnership with the Brazilian Association of Family, Friends and People with Affective Disorders (ABRATA).
• Supported the “Words Matter” project in Mexico to educate the media on how to speak and write about mental health conditions and treatments.

Education and Training

• Supported the development of a line of care guidelines in Brazil to improve access to care, reduce stigma and optimize diagnosis and treatment in primary care. The guidelines include clinical flowcharts, evidence-based treatment protocols, training for primary care doctors, continuous patient follow-up and integration with specialized mental health networks.

Government and Institutional Partnerships

• Signed a Memorandum of Understanding (MoU) with the Egyptian Ministry of Health to provide funding for the “Your Health is Happiness” program, part of the government’s broader 100 Million Health program. The program aims to include mental health screening for 2 million people and addresses issues such as depression, anxiety, autism, and addictions to substances, gaming and the internet in addition to supporting public awareness campaigns and capacity.

Research and Treatment Development

• Filed applications to the Ministry of Health, Labor and Welfare in Japan for approval of Effexor® to treat adults with generalized anxiety disorder, an indication for which no other treatment option is currently approved in Japan. Viatris in 2024 published Phase 3 study results into the treatment’s efficacy and safety.

Exploring Art in Spain to Understand and Address Mental Health

The Viatris Foundation in Spain brought together psychiatrists and art experts for a unique event at the Museo Nacional Centro de Arte Reina Sofía to explore new ways to understand and talk about mental health. Participants at the “La Mente sobre el Lienzo” – or “Mind on Canvas” – event included a guided tour of some of the museum’s most iconic works and discussion about how art can offer comfort, support and provide an outlet for expression to people living with mental health conditions.

During the tour, various works were examined in depth, each linked to a psychiatric analysis. Each work served as a starting point for reflecting on how art can symbolize deep emotions, life experiences and internal struggles often faced by those living with mental health conditions.

“Mental health has emerged as a serious global health challenge. We believe it is critical to show how art, beyond its artistic value, can be a powerful tool for introspection, emotional relief and creating a space where people living with mental health conditions can feel understood and supported.”

João M.
President of the Viatris Spain Foundation

Building Access Through Digital Health Solutions

We leverage evolving technology and innovative platforms for HCPs to better help patients. These web-based solutions, called digital therapeutics (DTx), are increasingly being used for a variety of medical conditions, including hypertension, cancer, substance use disorders and mental disorders. DTx are evidence-based interventions, with clinically evaluated software programs, often, but not necessarily, coupled with artificial intelligence techniques and machine learning systems to prevent, manage or treat medical conditions. Further, to reach remote areas and promote access to Viatris’ portfolio, we utilize digital tools to help HCPs serve patients in underserved locations more effectively.

In addition to being more readily available to patients, DTx have the potential to reduce the overall burden on healthcare systems and offer potential economic benefits to the public health system. In Europe, Viatris worked with external experts to publish a paper examining the levels of adoption of DTx in Europe and to explore possible strategies to improve adoption. The publication, titled “Adoption of Digital Therapeutics in Europe,” discusses the regulatory and reimbursement landscape across Europe, validation requirements for DTx and the importance of co-design and an ecosystem-centric approach in the development of DTx.

Other ways Viatris is supporting digital solutions for healthcare include the following:

• Launched WhatsApp Connect WACR, a program leveraging the popular messaging application to communicate medical information to nearly 2,000 HCPs in Malaysia.
• Launched Bliss DTx, an immersive, virtual reality solution to manage patients’ pain and anxiety and optimize the use of analgesics, anxiolytics and anesthetics in France.
• Supported the Egyptian Drug Authority (EDA) DAWANA digital tool designed to ensure safe and controlled dispensing of essential medications through a three- year grant. The platform is expected to be launched across all 29 governorates with more than 4,000 registered pharmacies.
• Established long-term collaborations in China with online health service platforms including Meituan Pharmacy and JD Health to improve the accessibility of out-of-hospital medical services and medications for patients. Viatris signed
  a strategic cooperation agreement with Alibaba Health Pharmacy to fully launch digital health services in areas such as online retail and disease education and to maximize the accessibility of non-hospital medications in the cardiovascular field.
• Supported Gravitate Health, a public-private partnership with 40 members from Europe and the U.S. that aims to empower people with digital information tools that make them confident, active and responsive in their patient journey, specifically encouraging safe use of medicines. Gravitate Health will also include an open-source digital platform supporting “G-Lens,” where users can have easy access to trusted health information.
• Supported the launch of the Score Diabetes application in Vietnam to help doctors detect and prevent atherosclerotic cardiovascular disease in diabetic patients more effectively. By providing clear visualizations of risk factors, the app facilitates improved patient communication and enhances clinical decision-making.
• Launched the Diabetic Peripheral Neuropathy Application in Thailand to promote education, screening, diagnosis and early intervention for neuropathic pain. The app is undergoing a three-month pilot at five institutes to improve early management and patient outcomes while supporting healthcare providers with valuable insights and relevant information.

Supporting the Appropriate Use of Medicines

Helping patients use medicines appropriately and adhere to prescriptions are crucial factors to improving health and well-being around the world. We promote the appropriate use of medicines and have several initiatives aimed at educating patients on medical conditions and ways to better manage them. We provide online portals, websites and mobile applications that offer features ranging from tracking symptoms to reminding patients about refilling prescriptions.

In addition, some digital solutions provide real-time guidance for healthcare providers to help them understand a patient’s overall status. We support individual dose dispensing across several European countries to increase therapeutic adherence and reduce medication errors, which is particularly important for elderly patients taking multiple medications.

View the full Viatris 2024 Sustainability Report.

^{Sources
1 Noncommunicable diseases
2 WHO Noncommunicable diseases fact sheet
3 WHO World Mental Health Report}

October 15, 2025 /3BL/ – The UK is setting a global benchmark in sustainability, driven by businesses that increasingly recognise the competitive, reputational, and financial advantages of sustainable practices. However, progress is uneven across sectors, as each industry faces distinct environmental, social, and governance challenges shaped by differing operational, regulatory, and market priorities. Recognising these differences is crucial to developing targeted strategies, prioritising actions, and implementing practices that deliver measurable sustainability outcomes.

To support businesses in strengthening competitiveness and resilience, the UN Global Compact Network UK, in collaboration with University College London, Newcastle University, and Euromonitor, has launched the report ‘Trailblazers & Transformers: UK Business Sectors Redefining Sustainability’, examining how six high-impact sectors in the UK are performing against the Sustainable Development Goals (SDGs). Drawing on rigorous data and market insights, the report identifies sector-specific challenges, benchmarks performance, and presents actionable recommendations to support effective sustainability strategies.

DOWNLOAD THE REPORT

You can now download the full report to:

• Gain in-depth analysis of UK business progress on the SDGs;
• Access sector-specific insights to strengthen ESG performance and support the integration of sustainability into strategy and operations;
• Understand cross-sector trends highlighting shared barriers, leadership gaps, and opportunities for collaboration and innovation;
• Inform your company’s sustainability strategy with evidence-based findings and global benchmark comparisons;
• Leverage data-driven insights from UN Global Compact Communication on Progress (CoP) data, World Benchmarking Alliance benchmarks, policy context, and market trends to guide decision-making; and
• Explore policy priorities that can shape the enabling environment to help businesses operate responsibly, compete globally, and unlock sustainable investment at scale.

You can find more information about the report here, and please share it with your networks.

Media Contact:
Lily Venables
Senior Project Manager (Governance and SDGs)
lily.venables@unglobalcompact.org.uk

Read More

This year marks a milestone for Southwire — our 75th anniversary. From Roy Richards, Sr.’s entrepreneurial vision to bring electric light to rural Georgia to a company that now stands strong with a legacy of excellence, the heart of our story remains the same: passion, innovation, integrity and a belief in doing things right.

While much has changed over the past 75 years, Southwire’s commitment to inclusion has remained unwavering.

We’re proud to launch our third annual Inclusion Report, showcasing our ongoing commitment to building a more inclusive organization and industry, shown through our key areas of focus on People Leaders, Inclusive Workforce, Employee Resource Groups, Reputation and Community, Equity and Governance and Value and Supply Chain.

From donating $1 million to inclusion-focused initiatives, to being named to Ethisphere’s World’s Most Ethical Companies® list, Southwire continues to operate responsibly and sustainably.

Our strong commitments to our communities, responsible and ethical sourcing and efforts to be an Extraordinary Place to Work for All ensures that we are focused on doing well, by doing good.

As we look to the next chapter, we remain wired for inclusion, wired for innovation and wired for progress. Together, we will continue building worth for our customers, communities and each other for generations to come.

To learn more about our progress and the people and programs driving inclusion at Southwire, we invite you to read the full Inclusion Report. It offers a deeper look at our commitments, achievements and continued journey. To read the report and learn more about Southwire’s inclusion initiatives, visit https://southwire.com/inclusion.

Originally published on newsroom.marykay.com

DALLAS, October 15, 2025 /3BL/ – The Mary Kay Ash Foundation®, an unwavering champion of advancing women’s cancer research, supporting survivors of domestic violence, and advocating for women’s health and safety, announced it has awarded nearly $3 million in cancer research and domestic violence shelter grants around the country. Since 1996, the Mary Kay Ash Foundation has given more than $98 million in support of its two-fold mission: eliminating women-related cancers and ending domestic violence.

Grants were awarded to the following organizations and focus areas:

2025 DOMESTIC VIOLENCE SUPPORT

• Annual Domestic Violence Shelter Grants (51 Grants | $1,020,000)
  Domestic violence shelters in 51 states and U.S. territories received $20,000 grants each totaling             over $1 million in unrestricted funds to support life-saving services such as legal aid, counseling, facility improvements, childcare, job readiness training, and more.
• Local Domestic Violence Shelter Grants (4 Grants | $100,000)
  Awarded four local domestic violence shelters across North Texas with $25,000 grants each totaling $100,000 to address specific community needs. Denton County Friends of the Family, Hope’s Door New Beginning Center, Genesis Women’s Shelter & Support, and The Family Place provide critical needs to women facing abuse.
• The National Domestic Violence Hotline ($70,000)
  Announced partnership with The National Domestic Violence Hotline (“The Hotline”) – the nation’s leading resource for survivors and those seeking to support them – to create a nationwide initiative focused on trauma-informed education, community engagement, and life-saving tools to help individuals recognize and respond to abuse. The partnership provides training webinars, downloadable resources, and a series of short videos.
• The Conference on Crimes Against Women ($75,000) 
  Supported for 19 consecutive years The Conference on Crimes Against Women (CCAW), an annual community multi-stakeholder conference in Dallas, Texas dedicated to addressing and combating all forms of crimes against women. Drawing 3,000 annually, CCAW is the only conference that addresses all crimes against women with a multidisciplinary focus that encourages a coordinated community response. The 20^th edition of the conference took place in May 2025. 

View a full list of 2025 Mary Kay Ash Foundation Domestic Violence Shelter Grant recipients.

2025 CANCER RESEARCH & PROGRAMS SUPPORT

• Translational Cancer Research Grants (10 Grants | $1,000,000)
  Awarded 10 esteemed cancer researchers from the nation’s leading accredited universities with individual grants of $100,000, totaling $1 million in funding. These competitive research grants support groundbreaking studies focused on cancers primarily affecting women.
• Baylor Scott & White Dallas Foundation Cancer Research & Support ($500,000)
  • Awarded a $100,000 grant to the Baylor Scott & White Dallas Foundation Amy Selkirk Breast Cancer Research Fund to further support the second year of a first of its kind clinical trial conducted by Joyce O’Shaughnessy, MD, Celebrating Women Chair in Breast Cancer Research. This trial explores weight loss inhibitors to prevent breast cancer recurrence in overweight patients.
  • Awarded a $400,000 multi-year grant in support of the newly established Texas Cancer Interception Institute, a first of its kind program utilizing cutting edge biomarker technology, circulating tumor DNA (ctDNA) blood-based assays offered on a huge scale to improve cancer care with an emphasis on early detection.
• CancerCare ($75,000)
  This year marks the 25^th anniversary partnering with CancerCare – the leading national organization dedicated to providing free, professional support services for those facing a cancer diagnosis. For 25 years, the Mary Kay Ash Foundation has funded CancerCare’s Touching Hearts program, providing financial assistance to economically disadvantaged women navigating a cancer diagnosis and treatment plan, resulting in over 50,000 grants totaling over $5.6 million in financial assistance.
• Cancer Support Community North Texas ($25,000)
  Local nonprofit, Cancer Support Community North Texas, received a $25,000 grant in support of free programs and services for those undergoing cancer treatment and their caregivers. Participants receive counseling, health and wellness classes, yoga and crafts, and more to help with healing and hope. 

View a full list of 2025 Mary Kay Ash Foundation Cancer Research Grant recipients.

“For nearly 30 years, the Mary Kay Ash Foundation has been guided by a simple notion: when women thrive, communities thrive,” said Michael Lunceford, President of the Mary Kay Ash Foundation Board of Directors. “From funding innovative women’s cancer research to strengthening services for survivors of domestic violence, at our core we are empowering communities, restoring hope, and giving women the chance to live longer, healthier, safer lives.”

The Mary Kay Ash Foundation has awarded more than $98 million to women’s shelters and domestic violence service providers, as well as cancer research programs and related causes throughout the U.S. For more information, visit marykayashfoundation.org  

***

About Mary Kay Ash Foundation® 
Guided by Mary Kay Ash’s dream to enrich the lives of women everywhere, the Mary Kay Ash Foundation® raises and distributes funds to end domestic violence and invest in breakthrough cancer research to find cures for women-related cancers. Since 1996, the Mary Kay Ash Foundation has contributed more than $98 million to organizations aligned with its two-fold mission. In addition, the Foundation supports awareness initiatives, community outreach programs, and advocates for legislation to ensure women are healthy and safe. Together, we can make the world better for women. To learn more about how to educate, advocate, volunteer, donate, and join life-saving work to support and empower women, visit marykayashfoundation.org, or find us on Facebook and Instagram.

###

ST. PAUL, Minn. and CHARLOTTE, N.C. October 15, 2025 /3BL/ – 3M (@3M) and Discovery Education (@DiscoveryEd) named Kevin Tang, an 8^th grader at Cedarlane Academy of the Hacienda La Puente Unified School District in Hacienda Heights, California, as the winner of the 2025 3M Young Scientist Challenge, the nation’s premier middle school science competition. Kevin distinguished himself with a novel fall detection device that can accelerate emergency responses to falls among older adults at home, even in the dark. As the grand prize winner, he received a $25,000 cash prize and the prestigious title of “America’s Top Young Scientist.”

Kevin spent the last four months competing against nine other finalists and ultimately secured himself the win during final Challenge events at 3M global headquarters in St. Paul, Minnesota, on Oct. 13 and 14. The finalists had to navigate a series of scientific tasks and were evaluated on their communication and presentation skills, ingenuity, innovative thinking, application of STEM principles, demonstration of passion and research, and the ability to inspire others. 

Kevin’s custom in-home device uses video analysis and smart alerts to protect older adults in their homes. It can recognize falls with high accuracy, even at night. Research from the U.S. Centers for Disease Control and Prevention finds that falls are the leading cause of injury among 1 in 4 older adults annually, or over 14 million people. Kevin created an algorithm that analyzes video input to identify falls and triggers alerts to loved ones via a corresponding smart phone application. His new solution advances current offerings on the market through the ability to capture imagery at night and provide around-the-clock monitoring. The device can also detect irregular movements while the individual is walking, which could be a symptom of a stroke.

“By tapping into their curiosity and reimagining what’s possible, these impressive finalists have developed solutions to real-world problems,” said Torie Clarke, 3M’s executive vice president and chief public affairs officer. “Year after year, the 3M Young Scientist Challenge demonstrates the power of science to create positive impact and emphasizes that the next great innovation can come from anywhere. We are so proud of this year’s competitors and can’t wait to see what they accomplish next.”

Each 3M Young Scientist Challenge finalist is paired with a 3M scientist who mentors and works with them one-on-one over the summer to transform their ideas from concept to prototype. This year’s winner was paired with Dr. Mark Gilbertson, research specialist, robotics and AI, Advanced Materials and Transportation.

“Kevin’s journey into the world of falls and strokes was sparked by personal experiences, and it’s inspiring to see how he’s using that to make a difference,” said Dr. Gilbertson. “His project is a powerful reminder of how science can be both personal and universal. I hope he continues diving deeper into robotics and AI – his potential in these fields is immense.”

The second and third place winners from the 2025 3M Young Scientist Challenge also receive special recognition, including a $1,000 prize. This year’s runners-up are:

• Amaira Srivastava from Gilbert, AZ, a 9^th grader at Arizona College Prep High School of the Chandler Unified School District
• Anirudh Rao from Lone Tree, CO, an 8^th grader at STEM School Highlands Ranch of the Douglas County School District

The remaining top finalists from the 2025 3M Young Scientist Challenge in alphabetical order by last name, are: 

• Shrey Arora from Collierville, TN, a 9^th grader at Collierville High School
  of Collierville Schools
• Divyam Desai from Frisco, TX, an 8^th grader at Lamar and Norma Hunt Middle School of the Frisco Independent School District
• Kiyara Gunawardena from Temecula, CA, a 6^th grader at iShine Student Center
  of Springs Charter Schools
• Isha Marla from Portland, OR, a 9^th grader at Jesuit High School
• Reanna Bhuyan Patel from Princeton, NJ, a 9^th grader at Princeton Day School
• Sheyna Patel from Longwood, FL, a 9^th grader at Orlando Science High School of Orange County Public Schools
• Aniket Sarkar from Folsom, CA, an 8^th grader at Sacramento Country Day School

“We are incredibly proud to continue our longstanding collaboration with 3M. During the tenure of this powerful partnership, the nation’s best and brightest have created innovative solutions to the world’s most complex problems. Congratulations to Kevin and each of the finalists. Your fantastic work gives me great hope for the future,” said Amy Nakamoto, executive vice president of corporate partnerships and marketing at Discovery Education.

Now in its 18^th year, the 3M Young Scientist Challenge continues to inspire and challenge middle school students to think creatively and apply the power of STEM to discover real-world solutions. Former America’s Top Young Scientists have given TED Talks, filed patents, founded nonprofits, and made the Forbes 30 Under 30 list. These young innovators have also been named TIME Magazine’s Kid of the Year; featured in The New York Times Magazine, Forbes, and Business Insider; and appeared on national television programs such as Good Morning America, The Kelly Clarkson Show, and more. In addition, a 3M Young Scientist Challenge Alumni Network was formed in fall 2022 and includes more than 100 former challenge winners, finalists, and mentors, who take part in networking opportunities and more.

The award-winning competition supplements the 3M and Discovery Education program Young Scientist Lab, which provides no-cost dynamic digital resources for students, teachers, and families to explore, transform, and innovate the world around them. All the resources are also available on Discovery Education Experience, the essential companion for engaged PreK-12 classrooms.

To download images from the 2025 science competition, click here. To learn more about the 3M Young Scientist Challenge and meet this year’s winners and finalists, visit youngscientistlab.com. 

###

About 3M
3M (NYSE: MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M.com/news.

About Discovery Education 
Discovery Education is the worldwide edtech leader whose state-of-the-art, PreK-12, digital solutions help educators engage all students and support higher academic achievement. Through award-winning multimedia content, instructional supports, and innovative classroom tools that are effective, engaging, and easy to use, Discovery Education helps educators deliver powerful learning experiences. Discovery Education serves approximately 4.5 million educators and 45 million students worldwide, and its resources are accessed in over 100 countries and territories. Through partnerships with districts, states, and trusted organizations, Discovery Education empowers teachers with essential edtech solutions that inspire curiosity, build confidence, and accelerate learning. Learn more at www.discoveryeducation.com.  

Contacts
3M
3MNews@mmm.com 

Grace Maliska
Discovery Education
gmaliska@discoveryed.com

This article is authored by Jenelle Shapiro, Sustainability and Circularity Leader, Trane Technologies

For most materials, the end of life is the end of the road. Final destination? Landfill.

But with circularity — the practice of keeping resources in use for as long as possible — that paradigm shifts. This vision that all materials are valuable resources can unlock new opportunities for decarbonization, economic sustainability and business innovation.

Recycling is a key lever in a circular system, bringing resources back into use by transforming yesterday’s “trash” into tomorrow’s value stream. At our Galway, Ireland manufacturing facility, we’re proving that the goal to send zero waste to landfill is possible at an industrial scale.

How circularity is delivering greener outcomes for the Emerald Isle

Our plant in Galway, Ireland has the capacity to manufacture over 100 Thermo King cold chain refrigeration units every day. A decade ago, the site sent upwards of 20 tons of waste to landfill each year. But in 2014, a cross-functional team set an ambitious target: to become Trane Technologies’ first zero-waste-to-landfill facility.

The plant is located between two residential neighborhoods near the beautiful Galway Bay, and the team needed to take a local approach to prioritize the community and minimize land degradation and air pollution.

They began by exploring every waste stream to identify how to capture its inherent value. Plastics, metals, cardboard, timber and other components are separated and collected by employees in every production area. Collaboration was also critical — the team engaged with regional partners to create innovative recycling alternatives for the generated waste.

Transparency is built into each stage of the reverse logistics ecosystem: every ounce of material that leaves the facility is collected, weighed and traced to its final destination. Leadership reviews monthly sustainability reporting, which includes waste management, and conducts regular audits to ensure long-term improvements.

This strategic system ensures that no material goes to waste. Scrap metals are reclaimed by a local recycler and processed into new raw materials, while non-reusable timber becomes garden mulch. Cardboard and paper are recycled for new packaging, and the minimal remaining materials are used to generate energy at a cement manufacturer — avoiding landfill entirely.

Why collaboration across the supply chain matters

More progress came when the team looked beyond the factory walls. Working with suppliers in multiple countries, the team reconceptualized standard packaging and shipping materials. The collaborations helped shift from single-use timber pallets and cardboard boxes to reusable crates and corrugated boxes that move between the factory and suppliers, a sustainable innovation in an effective reverse-logistics supply chain.

The results speak for themselves: from 2002 to 2012, Galway averaged 230 tons of landfill waste a year. By 2012, that figure had fallen to 20 tons, then to 2 tons in 2014. Since 2015, the facility has sent nothing to landfill for ten consecutive years.

This approach has created value for both our customers and our own business. The shift to returnable metal pallets saves on disposal costs by eliminating landfill fees and taxes, while reducing packaging resulted in raw material discounts.

And the environmental sustainability impacts are just as deep. Decarbonization initiatives like this support our broader business and sustainability strategies, propelling us toward carbon neutrality while supporting our customers in their own decarbonization goals.

How going beyond waste powers a decarbonized economy

Galway proves that zero-waste manufacturing is possible when systems, data and culture align, and the team’s success underscores that sustainable practices generate real value. As we work towards our 2030 sustainability commitments, Trane Technologies will continue scaling these practices as we continue designing systems for circularity and move toward carbon-neutral operations.

To learn more about circular systems, please read our article about how embracing circularity can drive business value.

Explore careers that make an impact at Trane Technologies.

LAWRENCEVILLE, N.J. — The Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization whose mission is to improve global health, recently announced a $1 million donation to the Patient Advocate Foundation. The Patient Advocate Foundation (PAF) is a national 501 (c)(3) non-profit organization that provides professional case management services and financial assistance free of charge to Americans with chronic, life threatening, and debilitating illnesses.

The $1 million donation from the BMS Foundation will enable PAF to expand its nationally recognized case management program. For nearly 30 years, PAF case managers have provided direct support to patients living with chronic and critical illnesses and their families. PAF assists in helping to manage healthcare access challenges, as well as insurance and affordability, with an intentional commitment to vulnerable and medically underserved communities.

PAF case managers help patients and their families maintain access to prescribed healthcare services and medications, navigate insurance barriers, find resources to support cost-of-living expenses during treatment, evaluate and sustain health insurance coverage, apply for disability and manage or reduce out-of-pocket medical and living expenses. In FY2025, PAF’s case management provided direct support and intervention to 13,551 individuals, collectively living with 773 unique diseases, making 30 contacts per case to bring resolution and securing over $17 million in debt relief.

In honor of Global Patient Week at Bristol Myers Squibb (BMS), an annual, week-long event honoring inspiring patients who are at the heart of the missions of both BMS and the BMS Foundation, the BMS Foundation made a donation to the Patient Advocate Foundation, to help improve access to essential care for patients.

“The BMS Foundation’s donation to the Patient Advocate Foundation reflects our deep commitment to increasing access to care for those who need it most,” said Catharine Grimes, President of the Bristol Myers Squibb Foundation. “By strengthening PAF’s capacity to help patients and caregivers navigate complex healthcare systems, we are empowering more people to overcome barriers to care and treatment. This partnership exemplifies the spirit of Global Patient Week—placing patients at the heart of our mission and advancing health equity through compassion, advocacy, and action.”

“We are honored to be the recipient of this impactful donation,” said Fran Castellow, MSEd, President, Operations of Patient Advocate Foundation. “The generous support from the Bristol Myers Squibb Foundation will have a profound impact on PAF’s ability to expand our support to patients and families in need of case management support. Each year, we receive more than twice the number of requests for case management assistance than we are able to support. This funding will help us close that gap—enabling us to deliver critical case management services and personalized support to more individuals facing serious health challenges who need help navigating access and affordability challenges that threaten their health outcomes and overall well-being.”

The BMS Foundation’s vision is to ensure that all people, regardless of where they live, can achieve their best possible health. They are committed to establishing strategic partnerships to build strong, sustainable local healthcare systems, ultimately transforming how care is delivered and helping to ensure improved health now and in the future.